Viewing Study NCT03407105


Ignite Creation Date: 2025-12-25 @ 3:30 AM
Ignite Modification Date: 2026-02-27 @ 4:05 PM
Study NCT ID: NCT03407105
Status: COMPLETED
Last Update Posted: 2018-01-23
First Post: 2018-01-17
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Dose-Escalation Study of MDX-010 Administered Monthly as Immunotherapy in Subjects Infected With Human Immunodeficiency Virus (HIV)
Sponsor: Bristol-Myers Squibb
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module